Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil

Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil

Background: Hematopoietic stem cell transplantation is a curative treatment for many patients with hematological disorders. Donor–recipient genetic disparity, especially involving the human leukocyte antigen system is a critical factor for transplant outcome. Objective: To evaluate retrospectively d...

Full description

Bibliographic Details
Main Authors:	Alessandra Paz, Lisandra Rigoni, Gustavo Fischer, Monise Schittler, Annelise Pezzi, Vanessa Valim, Alice Dahmer, Bruna Zambonato, Bruna Amorin, Filipe Sehn, Maria Aparecida da Silva, Liane Daudt, Lucia Silla
Format:	Article
Language:	English
Published:	Elsevier 2018-04-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137918300142

Similar Items

Characterization of Patients with Chronic Myeloid Leukemia Unresponsive to Tyrosine Kinase Inhibitors who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
by: Franceli Carvalho, et al.
Published: (2016-12-01)

DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
by: Annelise Pezzi, et al.
Published: (2012-01-01)

Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
by: Annelise Pezzi, et al.
Published: (2014-01-01)

Fiberoptic bronchoscopy in the diagnosis and therapeutic decision for respiratory infections in hematological febrile neutropenic patients
by: Luiza Bento, et al.
Published: (2014-06-01)

Fiberoptic bronchoscopy in the diagnosis and therapeutic decision for respiratory infections in hematological febrile neutropenic patients
by: Luiza Bento, et al.
Published: (2014-06-01)

Comment on: clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation
by: Liane Esteves Daudt
Published: (2012-01-01)

Células-tronco mesenquimais – caracterização, cultivo, propriedades imunológicas e aplicações clínicas
by: Bruna Amorin, et al.
Published: (2012-04-01)

Boas práticas clínicas e aspectos regulatórios em pesquisas com terapia celular
by: Bruna Pochmann Zambonato
Published: (2017)

Boas práticas clínicas e aspectos regulatórios em pesquisas com terapia celular
by: Bruna Pochmann Zambonato
Published: (2017)

Boas práticas clínicas e aspectos regulatórios em pesquisas com terapia celular
by: Bruna Pochmann Zambonato
Published: (2017)

High prevalence of anemia in children and adult women in an urban population in southern Brazil.
by: Lucia Mariano da Rocha Silla, et al.
Published: (2013-01-01)

Sobrevida de Pacientes Submetidos a Transplante Alogênico de Medula Óssea
by: Lillian Gonçalves Campos, et al.
Published: (2009-08-01)

Polimorfismo V89L do gene 5 α-redutase tipo II (SRD5A2) e a associação com o risco de câncer de próstata :
by: Amorin, Bruna
Published: (2015)

Ensaio clínico de segurança e exequibilidade : células-tronco mesenquimais para o tratamento da doença do enxerto contra o hospedeiro aguda resistente aos corticosteroides
by: Amorin, Bruna
Published: (2013)

Polimorfismo V89L do gene 5 α-redutase tipo II (SRD5A2) e a associação com o risco de câncer de próstata :
by: Amorin, Bruna
Published: (2015)

Ensaio clínico de segurança e exequibilidade : células-tronco mesenquimais para o tratamento da doença do enxerto contra o hospedeiro aguda resistente aos corticosteroides
by: Amorin, Bruna
Published: (2013)

Polimorfismo V89L do gene 5 α-redutase tipo II (SRD5A2) e a associação com o risco de câncer de próstata :
by: Amorin, Bruna
Published: (2015)

Ensaio clínico de segurança e exequibilidade : células-tronco mesenquimais para o tratamento da doença do enxerto contra o hospedeiro aguda resistente aos corticosteroides
by: Amorin, Bruna
Published: (2013)

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01)

Impact of Donor Age on Outcomes in Hematopoietic Stem Cell Transplantation
by: Einat Galamidi‐Cohen, et al.
Published: (2020-09-01)

Physical and Psychological Discomfort Experienced by Hematopoietic Stem-Cell Donors
by: Miok Kim, et al.
Published: (2020-03-01)

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
by: Elena Kum, et al.
Published: (2021-01-01)

Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
by: Olivier Féraud, et al.
Published: (2016-01-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

The use of donor-derived veto cells in hematopoietic stem cell transplantation
by: Eran eOphir, et al.
Published: (2012-05-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Amir Ali Hamidieh, et al.
Published: (2009-01-01)

Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe
by: Eliane Gluckman, et al.
Published: (2020-12-01)

Urgent need for a South Asian hematopoietic stem cell donor registry
by: Srinivasan Periathiruvadi
Published: (2018-01-01)

Donor-specific Anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation
by: Sarah Morin-Zorman, et al.
Published: (2016-08-01)

From Altruistic Perspective to Study the Donation Process of Hematopoietic Stem Cell Donors
by: Ji-yan Lyu, et al.

Sibling donor-derived myeloid sarcoma after hematopoietic stem cell transplant
by: Janelle Otsuji, et al.
Published: (2021-06-01)

Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.
by: Hui Wang, et al.
Published: (2012-01-01)

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients
by: Bianca E. Gama, PhD, et al.
Published: (2017-11-01)

The Risks and Related Factors of Cancer Among Allogeneic Hematopoietic Stem Cell Donors in Taiwan
by: Yun-Jung Tsao, et al.
Published: (2014)

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION
by: V. A. Lavrinenko, et al.
Published: (2018-07-01)

In utero hematopoietic cell transplantation: Induction of donor specific immune tolerance and postnatal transplants
by: William H. Peranteau
Published: (2014-11-01)

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML
by: Bita Fakhri, et al.
Published: (2017-01-01)

A telomerase em células-tronco hematopoéticas Telomerase in hematopoietic stem cells
by: Silvana Perini, et al.
Published: (2008-02-01)